Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page header.
    Difference
    0.0%
    Check dated 2026-01-15T05:09:19.000Z thumbnail image
  4. Check
    50 days ago
    Change Detected
    Summary
    Locations were consolidated into one Locations section with individual state subsections (California, Massachusetts, Nevada, Ohio, Oklahoma, Pennsylvania). This update is part of revision v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T19:53:39.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:49:06.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Deleted the generic government funding/operating status notice; the study content and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:28:52.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    The new screenshot shows only minor formatting and layout adjustments with no changes to core study details (title, conditions, eligibility criteria, locations, or results). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:10:11.000Z thumbnail image
  8. Check
    122 days ago
    Change Detected
    Summary
    Added an important government-operating-status notice and a new version tag v3.2.0; removed the old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T15:58:42.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.